Cargando…
Chetomin, a SARS-CoV-2 3C-like Protease (3CL(pro)) Inhibitor: In Silico Screening, Enzyme Docking, Molecular Dynamics and Pharmacokinetics Analysis
The emergence of the Coronavirus Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to over 6 million deaths. The 3C-like protease (3CL(pro)) enzyme of the SARS-CoV-2 virus is an attractive druggable target for exploring therapeutic drug c...
Autores principales: | Ibrahim, Mahmoud A. A., Abdelrahman, Alaa H. M., Mohamed, Dina E. M., Abdeljawaad, Khlood A. A., Naeem, Mohamed Ahmed, Gabr, Gamal A., Shawky, Ahmed M., Soliman, Mahmoud E. S., Sidhom, Peter A., Paré, Paul W., Hegazy, Mohamed-Elamir F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866112/ https://www.ncbi.nlm.nih.gov/pubmed/36680290 http://dx.doi.org/10.3390/v15010250 |
Ejemplares similares
-
SuperNatural inhibitors to reverse multidrug resistance emerged by ABCB1 transporter: Database mining, lipid-mediated molecular dynamics, and pharmacokinetics study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023) -
Exploring Natural Product Activity and Species Source Candidates for Hunting ABCB1 Transporter Inhibitors: An In Silico Drug Discovery Study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2022) -
Pyronaridine as a Bromodomain-Containing Protein 4-N-Terminal Bromodomain (BRD4-BD1) Inhibitor: In Silico Database Mining, Molecular Docking, and Molecular Dynamics Simulation
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023) -
In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2023) -
Exploring Toxins for Hunting SARS-CoV-2 Main Protease Inhibitors: Molecular Docking, Molecular Dynamics, Pharmacokinetic Properties, and Reactome Study
por: Ibrahim, Mahmoud A. A., et al.
Publicado: (2022)